Evidence map›Paper›PMID 37947613›Full record

ArticleCells2023

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures.

Evelyn Knappe, Franziska Rudolph, Christine Klein, Philip Seibler

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Evelyn KnappeInstitute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Franziska RudolphInstitute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Christine KleinInstitute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Philip SeiblerInstitute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.ORCID 0000-0002-3496-7194
University of Lübeck · DE

Funding

Deutsche Forschungsgemeinschaft FOR2488
6 · The paper itself

Abstract

Aside from the degeneration of dopaminergic neurons, inflammation is a key component in the movement disorder Parkinson's disease (PD). Microglia activation as well as elevated cytokine levels were observed in the brains of PD patients, but the specific role of microglia in the disease process is unknown. Here, we generate human cellular models by differentiating iPSCs into dopaminergic neurons and microglia. We combine these cells in co-culture to perform cytokine profiling, representing the final functional outcome of various signaling pathways. For this, we used unstimulated conditions and treatment with inflammatory stressors. Importantly, only co-cultures but not the monocultures responded to IL-1β treatment suggesting co-culture-related crosstalk. Moreover, we identified the main types of released cytokines and chemokines in this model system and found a preference for the activation of the chemotaxis pathway in response to all treatments, which informs future studies on the cell-type-specific reaction to inflammatory stimulation. Finally, we detected protein level changes in PD risk factor GPNMB upon stress in microglia, further confirming the link between PD-associated genes and inflammation in human-derived cellular models.

Indexed as

Induced Pluripotent Stem CellsParkinson DiseaseCytokinesDopaminergic NeuronsHumansInflammationMembrane GlycoproteinsMicrogliaCytokinesGPNMB protein, humanMembrane Glycoproteinsco-culturecytokine profilingdopaminergic neuronsiPSCmicrogliaParkinson’s disease

Identifiers

PMID37947613
PMCPMC10650774
OpenAlexW4388189991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.